CH564038A5 - - Google Patents
Info
- Publication number
- CH564038A5 CH564038A5 CH1295371A CH1295371A CH564038A5 CH 564038 A5 CH564038 A5 CH 564038A5 CH 1295371 A CH1295371 A CH 1295371A CH 1295371 A CH1295371 A CH 1295371A CH 564038 A5 CH564038 A5 CH 564038A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2046640A DE2046640C3 (de) | 1970-09-14 | 1970-09-14 | Verfahren zur Herstellung von Delta hoch 4 -3-Oxo-l alpha-methyl·Steroiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH564038A5 true CH564038A5 (en:Method) | 1975-07-15 |
Family
ID=5783070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1295371A CH564038A5 (en:Method) | 1970-09-14 | 1971-09-02 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3758523A (en:Method) |
| JP (1) | JPS5616159B1 (en:Method) |
| AT (1) | AT317450B (en:Method) |
| BE (1) | BE772580A (en:Method) |
| CA (1) | CA931945A (en:Method) |
| CH (1) | CH564038A5 (en:Method) |
| CS (1) | CS163256B2 (en:Method) |
| DE (1) | DE2046640C3 (en:Method) |
| DK (1) | DK131786C (en:Method) |
| ES (1) | ES394773A1 (en:Method) |
| FR (1) | FR2107603A5 (en:Method) |
| GB (1) | GB1366329A (en:Method) |
| IE (1) | IE35633B1 (en:Method) |
| NL (1) | NL172549C (en:Method) |
| SE (1) | SE373843B (en:Method) |
| YU (1) | YU34802B (en:Method) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2558090C2 (de) * | 1975-12-19 | 1985-05-30 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten |
| DE3115996A1 (de) * | 1981-04-13 | 1982-11-04 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | 17(alpha)-alkyl-17(beta)-hydroxy-1(alpha)- methyl-4-androsten-3-one-.verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten |
| DE3715869A1 (de) * | 1987-05-07 | 1988-11-17 | Schering Ag | Verfahren zur herstellung von 1-methyl-androsta-1,4-dien-3,17-dion und die neuen zwischenprodukte fuer dieses verfahren |
-
1970
- 1970-09-14 DE DE2046640A patent/DE2046640C3/de not_active Expired
-
1971
- 1971-09-01 DK DK428871A patent/DK131786C/da active
- 1971-09-02 CH CH1295371A patent/CH564038A5/xx not_active IP Right Cessation
- 1971-09-03 YU YU2249/71A patent/YU34802B/xx unknown
- 1971-09-03 ES ES394773A patent/ES394773A1/es not_active Expired
- 1971-09-08 SE SE7111383A patent/SE373843B/xx unknown
- 1971-09-09 CS CS6450A patent/CS163256B2/cs unknown
- 1971-09-09 IE IE1149/71A patent/IE35633B1/xx unknown
- 1971-09-10 US US00179537A patent/US3758523A/en not_active Expired - Lifetime
- 1971-09-13 JP JP7114471A patent/JPS5616159B1/ja active Pending
- 1971-09-13 FR FR7132928A patent/FR2107603A5/fr not_active Expired
- 1971-09-13 AT AT793071A patent/AT317450B/de not_active IP Right Cessation
- 1971-09-13 GB GB4255471A patent/GB1366329A/en not_active Expired
- 1971-09-14 CA CA122821A patent/CA931945A/en not_active Expired
- 1971-09-14 BE BE772580A patent/BE772580A/xx not_active IP Right Cessation
- 1971-09-14 NL NLAANVRAGE7112649,A patent/NL172549C/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5616159B1 (en:Method) | 1981-04-14 |
| NL7112649A (en:Method) | 1972-03-16 |
| DK131786B (da) | 1975-09-01 |
| SE373843B (en:Method) | 1975-02-17 |
| CS163256B2 (en:Method) | 1975-08-29 |
| ES394773A1 (es) | 1974-03-01 |
| FR2107603A5 (en:Method) | 1972-05-05 |
| DK131786C (da) | 1976-02-02 |
| BE772580A (fr) | 1972-03-14 |
| NL172549C (nl) | 1983-09-16 |
| YU34802B (en) | 1980-03-15 |
| DE2046640C3 (de) | 1973-10-18 |
| DE2046640A1 (de) | 1972-03-16 |
| AT317450B (de) | 1974-08-26 |
| CA931945A (en) | 1973-08-14 |
| US3758523A (en) | 1973-09-11 |
| NL172549B (nl) | 1983-04-18 |
| YU224971A (en) | 1979-09-10 |
| DE2046640B2 (de) | 1973-03-22 |
| IE35633B1 (en) | 1976-04-14 |
| IE35633L (en) | 1972-03-14 |
| GB1366329A (en) | 1974-09-11 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |